30 likes | 105 Views
Explore Circon's performance and strategic decisions leading to its acquisition by Maxxim Medical in November 1998. Includes key events such as offers, board decisions, and leadership changes.
E N D
Circon (A) Case April 20, 2006
Circon’s Performance • Offer by U.S. Surgical first made August 2, 1996 for $18/share when share price was around $12-1/8 • Offer lowered to $17 on December 14, 1996 • Offer limited to 14.9% of shares at $14.50 on June 16, 1997 • Offer to buy remainder at $16.50 until offer dropped on September 15, 1998
Board meeting October 16, 1998 • Auhll agreed to resign • Shares fell to $8.25 • Cloutier named interim CEO assigned goal to engineer sale of company • Circon sold in November 1998 to Maxxim Medical for $15/share